Literature DB >> 17712818

The toxicology of cannabis and cannabis prohibition.

Franjo Grotenhermen1.   

Abstract

The acute side effects caused by cannabis use are mainly related to psyche and cognition, and to circulation. Euphoria, anxiety, changes in sensory perception, impairment of memory and psychomotor performance are common effects after a dose is taken that exceeds an individually variable threshold. Cannabis consumption may increase heart rate and change blood pressure, which may have serious consequences in people with heart disease. Effects of chronic use may be induction of psychosis and development of dependency to the drug. Effects on cognitive abilities seem to be reversible after abstinence, except possibly in very heavy users. Cannabis exposure in utero may have negative consequences on brain development with subtle impairment of cognitive abilities in later life. Consequences of cannabis smoking may be similar to those of tobacco smoking and should be avoided. Use by young people has more detrimental effects than use by adults. There appear to be promising therapeutic uses of cannabis for a range of indications. Use of moderate doses in a therapeutic context is usually not associated with severe side effects. Current prohibition on cannabis use may also have harmful side effects for the individual and the society, while having little influence on prevalence of use. Harm is greatest for seriously ill people who may benefit from a treatment with cannabis. This makes it difficult to justify criminal penalties against patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17712818     DOI: 10.1002/cbdv.200790151

Source DB:  PubMed          Journal:  Chem Biodivers        ISSN: 1612-1872            Impact factor:   2.408


  18 in total

Review 1.  Animal models of cannabinoid reward.

Authors:  Leigh V Panlilio; Zuzana Justinova; Steven R Goldberg
Journal:  Br J Pharmacol       Date:  2010-06       Impact factor: 8.739

Review 2.  Blurred boundaries: the therapeutics and politics of medical marijuana.

Authors:  J Michael Bostwick
Journal:  Mayo Clin Proc       Date:  2012-02       Impact factor: 7.616

3.  Substance Use Among Adolescents with Attention-Deficit/Hyperactivity Disorder: Reasons for Use, Knowledge of Risks, and Provider Messaging/Education.

Authors:  Elizabeth Harstad; Lauren E Wisk; Rosemary Ziemnik; Qian Huang; Parissa Salimian; Elissa R Weitzman; Sharon Levy
Journal:  J Dev Behav Pediatr       Date:  2017 Jul/Aug       Impact factor: 2.225

Review 4.  Cannabis in sport: anti-doping perspective.

Authors:  Marilyn A Huestis; Irene Mazzoni; Olivier Rabin
Journal:  Sports Med       Date:  2011-11-01       Impact factor: 11.136

5.  Aryl Piperazinyl Ureas as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) in Rat, Dog, and Primate.

Authors:  John M Keith; Rich Apodaca; Mark Tichenor; Wei Xiao; William Jones; Joan Pierce; Mark Seierstad; James Palmer; Michael Webb; Mark Karbarz; Brian Scott; Sandy Wilson; Lin Luo; Michelle Wennerholm; Leon Chang; Sean Brown; Michele Rizzolio; Raymond Rynberg; Sandra Chaplan; J Guy Breitenbucher
Journal:  ACS Med Chem Lett       Date:  2012-08-22       Impact factor: 4.345

Review 6.  Evidence-based Treatment Options in Cannabis Dependency.

Authors:  Lisa Walther; Andreas Gantner; Andreas Heinz; Tomislav Majić
Journal:  Dtsch Arztebl Int       Date:  2016-09-30       Impact factor: 5.594

7.  Tasty THC: Promises and Challenges of Cannabis Edibles.

Authors:  Daniel G Barrus; Kristen L Capogrossi; Sheryl C Cates; Camille K Gourdet; Nicholas C Peiper; Scott P Novak; Timothy W Lefever; Jenny L Wiley
Journal:  Methods Rep RTI Press       Date:  2016-11

8.  Clinical Pharmacokinetics of Cannabinoids and Potential Drug-Drug Interactions.

Authors:  Marta Vázquez; Carlos García-Carnelli; Cecilia Maldonado; Pietro Fagiolino
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

Review 9.  The therapeutic potential of cannabis and cannabinoids.

Authors:  Franjo Grotenhermen; Kirsten Müller-Vahl
Journal:  Dtsch Arztebl Int       Date:  2012-07-23       Impact factor: 5.594

10.  Interest in marijuana treatment programs among teenage smokers and nonsmokers.

Authors:  Amy J Sheer; David A Gorelick; Charles C Collins; Jennifer R Schroeder; Stephen J Heishman; Michelle K Leff; Eric T Moolchan
Journal:  J Subst Abuse Treat       Date:  2009-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.